Showing 3331-3340 of 18626 results for "".
Echo essentials for HCM: The heartbeat of diagnosis and treatment
https://reachmd.com/programs/cme/echo-essentials-for-hcm-the-heartbeat-of-diagnosis-and-treatment/26967/Three HCM experts discuss the role of echocardiography and other imaging techniques in the diagnosis and treatment of HCM.Spotlight on Asia-Pacific: Practice Beyond Borders
https://reachmd.com/programs/cme/spotlight-on-asia-pacific-practice-beyond-borders/39810/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC
https://reachmd.com/programs/cme/doublet-or-triplet-a-case-based-debate-in-first-line-choices-for-hrher2-mbc/39806/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.Spotlight on Latin America: Closing the Gap
https://reachmd.com/programs/cme/spotlight-on-latin-america-closing-the-gap/39809/Examine evolving global strategies for treating patients with HR+/HER2- mBC, integrating biomarker-driven therapy, clinical evidence, and toxicity management.Enlisting Students in the Fight Against COVID-19: Helpful or Harmful?
https://reachmd.com/programs/covid-19-frontlines/enlisting-students-fight-against-covid-19-helpful-or-harmful/11325/Medical students are increasingly being thrust into frontline efforts to combat COVID-19. Will this help stem the tide, or compound the crisis?Latest TROP2 ADC Approval for HR+ HER2- Metastatic Breast Cancer
https://reachmd.com/programs/medical-industry-feature/latest-trop2-adc-approval-for-hr-her2-metastatic-breast-cancer/29175/There’s been recent progress with antibody-drug conjugates (ADCs) for HER2-negative breast cancers,1-3 and most recently, patients with metastatic HR+ HER2- breast cancer. The phase III TROPION-Breast01 study examined the efficacy and safety of datopotamab deruxtecan-dInk (Dato-DXd) compared to inveBehavioral Strategies for Managing Weight
https://reachmd.com/programs/lipid-luminations/behavioral-strategies-for-managing-weight/5386/This week's guest says that Americans eat an average of 200 calories more than they need every day. A variety of behavioral and emotional issues account for the reasons why. How can we help our patients change their habits? And what new habits will help them the most? The answer may lie in small chaTaking the Leap Into Private Practice
https://reachmd.com/programs/practical-dermatology/taking-the-leap-into-private-practice/24042/Practice is hard. Private practice is even harder.Women in Aesthetics: Divya Gugnani of Wander Beauty
https://modernaesthetics.com/topics/skincare/women-in-aesthetics-divya-gugnani-of-wander-beauty/35222/The Psychosocial Dermal Axis
https://modernaesthetics.com/topics/skincare/the-psychosocial-dermal-axis/35421/It’s time for psychiatry, dermatology, and aesthetic medicine to unite and explore.